Rituximab
Not Tagged
['ritux', 'lymsm', 'ts,perio,i', 'rituximab']
congress|#asco23 steven le gouill presents follow-up data from the lyma trial evaluating efficacy and safety of rituximab maintenace post asct in patients with mcl. ritiuximab was statistically superior in median efs and pfs with no major toxicities reported #lymsm 
A global education platform providing clinical updates on a range of lymphoma subtypes and chronic lymphocytic leukemia (#CLL) #lymsm